Post 1947 after the independence the company launched a series of branded Ayurvedic formulations like Shilapravang, Drakshovin , Kumarex, Ashotone, etc… and employed advertising agencies for the publicity and propaganda. In al,l 26 depots were opened by the company and intensive marketing was undertaken in 8 major states of India. Modern technology was being employed in the packaging of the products and dosage presentations.
In the 1950’s and 1960’s, the company launched its own publication by the name of Arogyamandir and organised a series of All India Ayurvedic Congress symposiums in Panvel. The plant in Panvel was working at rated capacity and there was an urgent need for expansion and consolidation of the product portfolio. In 1973, the company commissioned a second manufacturing unit at Bangalore in the southern state of Karnataka. This was a plant designed to manufacture Asavarishtas at a capacity of 150,000 liters per month.
In 1975, the company launched a few products under the brand names of Myostaal, Afrodet and Afrol as part of the solumiks division. The name ‘Solumiks’ means ‘soluble mixtures’. This division employed the Ethical route of marketing its products to the modern medical practitioner. The product portfolio was increased to 16 brands by the year 1990 and encompassed products in the therapeutic segments of Arthritis, Hepato protective, GI Tract disorders, etc…
The focus of the company in catering to the needs of the consumer changed from the traditional products to the branded products. Ethical marketing became the forte of the company. In 1998 the company spun the Solumiks division in a separate marketing company. The sole focus of this new entity was achieving market leadership in Ayurvedic Ethical formulations.
Shree Dhootapapeshwar is the oldest Ayurvedic Company in the world situated at Panvel near Mumbai and is today a benchmark for quality formulations.

ORGANISATIONAL SET UP

Solumiks Herbaceuticals Limited (SHL): SHL was established in October, 1998 and since then has registered an impressive growth over the last few years and is slated to grow at a CAGR of 7% over the next few years. The product development capability of SDL has been activated to deliver time tested formulations in therapeutic areas that were not addressed by the earlier product range. Clinical trials to validate claims and safety studies to assure the medical fraternity have been initiated. The full impact of all these initiatives would be seen in the coming years.

Traditional Range: This is the range of products that was first manufactured by the company since inception. The goodwill of the group has been earned through the consistent quality production of these seemingly simple formulations. The manufacture of traditional Ayurvedic formulations may involve some of the most common raw materials but the processing involves high technological depth. Ayurveda is very clear and exacting on the standards that have to be maintained for the production production protocols. Over the years the production capacities have been given the benefit of modern machines and technological advancement but the basic spirit and processing remains unchanged. Faster and Cheaper have never been the key guiding lights for enabling change in production operations. SDL has always believed in the sanctity of the Spirit behind the Letter as prescribed Ayurveda. The Panvel Plant manufactures product categories like Bhasma, Rasayanas, Arka, Avalehas and other Ayurvedic specialties. This is a plant that has been established in the year 1872 and the company plans to shift the operations to a nearby area to enable updation in production infrastructure.
The marketing of this range of products is today’s main focus area for the company. With the formation of a new entity for Solumiks the entire marketing personnel and distribution network went to the benefit of SHL. Today within the course of three years SDL has re-established the network and a field force of 65 personnel. By the year end we would be represented in 85 Head Qyarters in 6 states. The aim of this division is to grow at a CAGR of 33% for the next few years.